|
|
||||||||
Guest Access | Sign In via User Name/Password |
|||||||||
* From the Service de Radiologie (Drs. Bazot, Benayoun, Tassart, Bigot, and Carette) and de Pneumologie et Réanimation Respiratoire (Dr. Cadranel), Hôpital Tenon, Paris, France.
Correspondence to: Marc Bazot, MD, Service de Radiologie, Hôpital Tenon, 4 rue de la Chine, 75020 Paris, France; e-mail: marc.bazot{at}tnn.ap-hop-paris.fr
| Abstract |
|---|
|
|
|---|
Materials and methods: Seven chest radiographs and seven CT scans of HIV-infected patients with histologically proved primary pulmonary non-Hodgkins lymphoma (PPL) were reviewed at our institution. All of the patients had fibroscopy with BAL. The diagnosis of PPL was established histologically by means of PTNB (n = 4), open-lung biopsy (n = 2), or autopsy (n = 1).
Results: All but one patient had multiple peripheral well-defined nodules of various sizes on the chest X-ray film and CT scan. One patient had a subpleural parenchymal infiltrate and another had a main peripheral mass with spontaneous cavitation. Hilar/mediastinal adenopathies and pericardial/pleural effusion were never associated with the parenchymal abnormalities. Fibroscopy with BAL was always negative. PTNB, done in six cases, was diagnostic in four cases and suggested primary ARLL in two cases. No complications occurred during these procedures.
Conclusion: After excluding infectious causes, multiple peripheral nodules and/or masses without hilar or mediastinal adenopathies and without pleural effusion are suggestive of primary pulmonary ARL. A specific diagnosis can be obtained by means of PTNB.
Key Words: AIDS CT lung biopsy lymphoma
| Introduction |
|---|
|
|
|---|
| Materials and Methods |
|---|
|
|
|---|
Patients
All of the patients were men. Six were homosexual, one was
an IV drug user, and one was infected by blood transfusion. Their mean
age was 37 years old (range, 31 to 52 years old). All had already had
AIDS-related infections and their CD4+ cell
counts were < 50 cells/µL. None had cutaneous KS. All
presented with weight loss and fever between 38.5°C and 40°C; no
opportunistic infections were found, except for a case of
Pneumocystis carinii pneumonia (PCP). The correct
diagnosis was delayed by erroneous diagnoses in five of the seven
patients (four infections and one suspected thromboembolism).
Fiberoptic bronchoscopy and BAL were performed in every case and did
not reveal macroscopic lesions. BAL was negative in all seven cases for
the diagnosis of primary pulmonary NHL. The case of PCP was
diagnosed by BAL. The mean survival rate was 6.4 months (range,
1 to 17 months).
CT and PTNB
The CT scans were obtained at 10-mm intervals throughout the
chest with 1- to 2-mm collimation (n = 4) or 10-mm collimation
(n = 3). The 1- to 2-mm collimation scans were reconstructed with a
high-spatial-frequency algorithm. CT was performed with IV-administered
contrast material in all but one patient. Images were viewed at the
lung and mediastinal window settings. CT scans were assessed for the
presence and anatomic location of parenchymal disease, pleural
effusion, and mediastinal adenopathies. Nodules were defined as focal
opacities of various sizes (
30 mm in diameter), and could be well
defined or ill-defined. Tumor masses (> 30 mm in diameter) were
defined with or without air bronchograms. Mediastinal lymphadenopathy
was considered to be present when the short-axis diameter of the nodes
was
10 mm.
All but one patient underwent PTNB evaluation for the diagnosis of ARRL. The patient without PTNB was first suspected of having a pulmonary embolism and was the first patient in this series. CT guidance was used for PTNB, which was done using a coaxial technique in every case. An 18-gauge outer needle served as a conduit for an inner 20-gauge needle. A cytopathologist, who was present during all of the procedures, performed fast staining of aspirated specimens followed by immediate microscopic examination.
All tissue samples were reviewed by the same pathologist. Primary pulmonary NHL was classified according to the updated Kiel classification6 and equivalents in the National Cancer Institute Working Formulation7 on the basis of sections routinely stained with hematoxylin-eosin and Giemsa. Histologic assessment was completed with immunohistochemical analysis of paraffin sections using the streptavidin biotin peroxidase method. The following T-cell, B-cell, and epithelial cell markers were studied: anti-CD20, CD3, CD45, and CD30 (DAKO; Trappes, France) antibodies, anti-KL1 (Immunotech; Marseille, France), and anti-EMA antibodies (DAKO, Trappes, France), respectively. In some cases, additional immunohistochemical studies were done on frozen sections by using anti-CD19, CD2, CD4, CD5, CD7, and CD8 antibodies (DAKO). Genotypic evaluation based on Ig or T-cell receptor gene rearrangement analysis was not performed because of the retrospective nature of the study.
| Results |
|---|
|
|
|---|
|
|
|
|
|
|
| Discussion |
|---|
|
|
|---|
As in the report by Carignan et al,4 nodules of various size or mass were the most common finding in our series. These nodules were multiple in 85.7% of the cases and were exclusively located in the subpleural areas of the lung bases. In three patients, an air bronchogram was present, and one patient had a mass with cavitation before treatment. A diffuse ground-glass pattern was present once and was attributed to PCP. A halo sign has been described in ARL.4 In this latter paper it corresponded to a nodule with a halo of ground-glass attenuation, this aspect being very different from the diffuse ground-glass pattern observed in our series.
Right-sided pleural effusion was observed once, but only after OLB. This postoperative effusion was not related to lymphoma because an autopsy, done 1 month after the OLB, confirmed the exclusive involvement of the lung. The absence of pleural effusion and/or a pleural mass is a major difference with other reports of lymphoma of the chest. In the report of Sider et al,3 pleural effusion was the most common finding, occurring in 72.7% of the cases; in 62.5% of these cases, the diagnosis of ARL was based on cytologic study of fluid obtained at thoracentesis or histologic study of pleural biopsy material.
Lymphadenopathy can occur in ARL, but by definition, was absent in our cases. The presence of adenopathies may point to disseminated disease. Indeed, two of nine patients had mediastinal adenopathies in the report of Carignan et al4 ; one had lymphomatous heart invasion and the second had pleural effusion. The latter authors considered that mediastinal adenopathies were present when the long-axis diameter (and not the short-axis diameter as in our study) was > 10 mm.
In our patients with primary ARL of the lung (ARLL), multiple nodules and/or masses were the most frequent finding. However, these features are nonspecific, and the fever, which is always present, at least in our series, can be misleading. Differential diagnoses include tumoral lesions (eg, KS, lung cancer, and metastasis) and infections (mycobacteriosis, cryptococcosis, cytomegalovirus pneumonia, nocardiosis, and others). In four patients, nonspecific antibiotic therapy was begun because the parenchymal abnormalities were initially attributed to various potential infections. All our patients previously underwent bronchofibroscopy with BAL, which, except for one case in which PCP was associated with ARLL, was always negative for ARLL but ruled out infectious diseases and Kaposis lesions.
All but one of our patients had PTNB, which had a high diagnostic yield (two suggestive diagnoses and four definitive diagnoses). The high diagnostic yield of PTNB for lymphomatous disease seems to be related to the high malignant grade of the tumoral process. This indicates that small specimens are sufficient for diagnosis. Our data do not agree with those of Scott and Kuhlman,11 who suspected that the success rate of PTNB in lymphoma would be lower than it is in other malignancies because of the larger specimen size required for diagnosis. Indeed, in four of six patients, a specific diagnosis of lymphoma was obtained by means of PTNB. In one patient, the biopsy showed a tumoral process suggestive of a sarcoma. The final diagnosis obtained by OLB was that of a non-B, non-T lymphoma with a pseudosarcomatous aspect. In another patient, the biopsy showed lymphomatous infiltration, and the final autopsy diagnosis disclosed a B-cell lymphoma. No PTNB-related complications were observed in our series. The absence of complications (especially pneumothorax) may be attributed to the peripheral topography of the parenchymal lesions (ie, their location near the chest wall).
In conclusion, after excluding infectious diseases, multiple peripheral nodules and/or masses without associated hilar or mediastinal adenopathies and without pleural effusion are suggestive of primary pulmonary ARLL. Like Gruden et al,12 we think that PTNB is a safe and effective diagnostic procedure for focal thoracic disease, particularly, suspected primary ARLL.
| Footnotes |
|---|
Received for publication December 16, 1998. Accepted for publication May 14, 1999.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
H. Masur Management of Patients with HIV in the Intensive Care Unit. Proceedings of the ATS, January 1, 2006; 3(1): 96 - 102. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Cadranel, M. Wislez, and M. Antoine Primary pulmonary lymphoma Eur. Respir. J., September 1, 2002; 20(3): 750 - 762. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |